The Elicitation of an Antigen-Specific Antibody Immune Response Using a Nanoparticulate Adjuvant Derived from Saponaria officinalis

Molecules, 2025

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.3390/molecules30163328
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

The use of vaccines incorporating subunit proteins and viral components has significantly increased in recent decades, emphasizing the need for more effective and modular adjuvants. This study examined saponins from Saponaria officinalis, regarded as one of the most promising plant sources for developing an adjuvant platform using nanocomplex formation. A nanoparticle adjuvant containing saponins from Saponaria officinalis can be used to stimulate a humoral immune response; this ability was demonstrated using a model that included various viral proteins. The humoral immune response enhanced by saponin-containing adjuvants can increase from four to sixteen times, depending on the type of antigen used. Additionally, this response surpasses that triggered by antigens paired with aluminum hydroxide and is comparable to responses induced by adjuvants that contain Quil A. The further investigation of these platforms may yield a broader range of immunostimulants that can enhance vaccine effectiveness.